Ventavis Price To Be Based On Input From Payors And Physicians, CoTherix Says
CoTherix will base its price for the inhaled pulmonary arterial hypertension therapy Ventavis on the outcome of ongoing discussions with payors and physicians
CoTherix will base its price for the inhaled pulmonary arterial hypertension therapy Ventavis on the outcome of ongoing discussions with payors and physicians